Operating Margin
-1445%
Quarter · Through 31 Jul 2026
Luvulis Corp financial metrics
Period Q3 2026 · Filed 31 Aug 2026
Key metrics snapshot
Current Ratio
0.13x
Period-end balance · Through 31 Jul 2026
Profitability
| Metric | Latest value | YoY relative change |
|---|---|---|
| Operating Margin |
-1445%
Quarter · 31 Jul 2026
|
Financial Health
| Metric | Latest value | YoY relative change |
|---|---|---|
| Current Ratio |
0.13x
Period-end balance · 31 Jul 2026
|
Growth
| Metric | Latest value | YoY relative change |
|---|---|---|
| Revenues |
$833
Reported period · 31 Jul 2026
|
|
| Net Income (Loss) Attributable to Parent |
$12,035
Reported period · 31 Jul 2026
|
Share Metrics
| Metric | Latest value | YoY relative change |
|---|---|---|
| Entity Common Stock, Shares Outstanding |
2,000,000
Period-end balance · 31 Aug 2026
|
|
| Common Stock, Shares, Outstanding |
2,000,000
Period-end balance · 31 Jul 2026
|
|
| Common Stock, Value, Issued |
$2,000
Period-end balance · 31 Jul 2026
|
|
| Weighted Average Number of Shares Outstanding, Basic |
2,000,000
Reported period · 31 Jul 2026
|
Supporting Metrics
These supporting metrics stay fully source-backed for deeper research. Scan the latest value and reported period first, then open a metric page when you need the full filing trail.
| Metric | Latest value | YoY relative change |
|---|---|---|
| Additional Paid in Capital |
$6,000
Period-end balance · 31 Jul 2026
|
|
| Amortization of Intangible Assets |
$4,397
Reported period · 31 Jul 2026
|
|
| Assets |
$70,446
Period-end balance · 31 Jul 2026
|
|
| Assets, Current |
$12,825
Period-end balance · 31 Jul 2026
|
|
| Cash and Cash Equivalents, at Carrying Value |
$312
Period-end balance · 31 Jul 2026
|
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$312
Period-end balance · 31 Jul 2026
|
|
| Common Stock, Par or Stated Value Per Share |
0.001
Period-end balance · 31 Jul 2026
|
|
| Common Stock, Shares Authorized |
75,000,000
Period-end balance · 31 Jul 2026
|
|
| Common Stock, Shares, Issued |
2,000,000
Period-end balance · 31 Jul 2026
|
|
| Earnings Per Share, Basic |
-0.01
Reported period · 31 Jul 2026
|
|
| General and Administrative Expense |
$8,471
Reported period · 31 Jul 2026
|
|
| Intangible Assets, Net (Excluding Goodwill) |
$57,621
Period-end balance · 31 Jul 2026
|
|
| Liabilities |
$98,520
Period-end balance · 31 Jul 2026
|
|
| Liabilities and Equity |
$70,446
Period-end balance · 31 Jul 2026
|
|
| Liabilities, Current |
$98,520
Period-end balance · 31 Jul 2026
|
|
| Operating Income (Loss) |
$12,035
Reported period · 31 Jul 2026
|
|
| Retained Earnings (Accumulated Deficit) |
$36,074
Period-end balance · 31 Jul 2026
|
|
| Stockholders' Equity Attributable to Parent |
$28,074
Period-end balance · 31 Jul 2026
|
Comparisons, sources and research notes
Sources and sharing
Luvulis Corp Financial Facts
- Context
- Latest metrics period: Q3 2026
- Latest reported value
- Operating Margin -1445%
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open metric pages to inspect the reported history.
Tracking and update notes
Why revisit this company facts page
Company facts change as new 10-Q and 10-K filings update the latest reported period, headline values, and cross-company comparison context.
- Latest source-backed update
- Latest metrics period Q3 2026
- Why come back
- Use the next filing cycle to compare new facts against this baseline and then verify the detailed metric history.
- Current latest metrics period: Q3 2026.
- Most recent SEC facts end date on this page: 31 Aug 2026.
- Save this filer to return when the next filing-backed metric period changes the picture.
Freshness comes from the latest SEC company facts period available for this filer and the linked metric history pages.
Latest update
Latest update for Luvulis Corp
Latest financial period: Q2 2026. Reopen this facts page to verify the newest reported period against the prior baseline.
Update date
31 Aug 2026
Page type
Company facts
Latest period
Q3 2026
SEC-backed company facts were refreshed from filings filed on 31 Aug 2026.
Benchmark Context
How Operating Margin compares
Operating Margin does not yet have enough prior-period data for a historical comparison on this page.
Compared with
Compared with Luvulis Corp's recent history first. Same-industry peer context appears only when enough SEC-backed benchmark coverage exists.
Why this is notable
Operating Margin already has a self-history signal here, but same-industry benchmark context waits until the benchmark sample is strong enough.
- Latest comparable period on this page: Q3 2026.
- Peer context will appear when enough companies report a comparable value for this metric.
- Open the metric history first if you want to verify the exact period-to-period change.
Industry benchmark context uses SEC-reported values from the same methodology version. Latest periods may differ across companies.
Filing notes and source
Key facts
- Luvulis Corp financial facts use SEC filings; any third-party reference is labeled separately.
- Latest metrics period on this page: Q3 2026.
- Headline metric: Operating Margin -1445%.
Change
- Comparable YoY change is unavailable for this metric.
- Most recent SEC facts end date: 31 Aug 2026.
Research use
- This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
- Metric cards link to SEC history; a third-party reference may use a different or unverified reporting period.
Evidence
Based on latest 10-Q/10-K
View source filing
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open company facts to inspect the reported metric history.
Latest financial snapshot (2026-08-31) highlights Operating Margin -1444.8% and Current Ratio 0.13x.
Valuation Snapshot
SEC-only DCF estimate using a normalized free cash flow base, cash, debt, and reported share count when available.
No market comparison
DCF estimate is unavailable because required valuation inputs are missing.
Missing: Free cash flow.
Data confidence notes
- Free cash flow unavailable: operating cash flow or capex is missing
- Ticker missing for issuer
- Valuation unavailable: free cash flow is missing
Financial Quality Score
Transparent 0-100 scoring model based on profitability, financial health, and growth factors.
9.2/100
Weak Confidence low
Financial Health
- Current Ratio
- 0.13x
Strengths
No strong signals yet.
Watchpoints
Operating Margin and Current Ratio
Calculation methodology and other links
How we score
This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.
| Metric | Weight | V1 threshold |
|---|---|---|
| ROIC | 20 | 5% to 20% |
| ROE | 15 | 8% to 25% |
| ROA | 10 | 2% to 10% |
| Operating Margin | 5 | 5% to 25% |
| Current Ratio | 12 | 1.0x to 2.0x |
| Quick Ratio | 8 | 0.8x to 1.5x |
| Debt to Equity | 10 | 0.3x to 2.0x (lower is better) |
| Revenue YoY | 10 | -10% to +20% |
| Net Income YoY | 10 | -10% to +20% |
How Calculated (standard_v1)
Metrics are computed with a market-consensus convention designed for cross-portal comparability.
- Operating Income / Revenues using matching TTM or quarter periods; basis shown per metric
- Current Assets / Current Liabilities (latest instant quarter)
- (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
- Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
- TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
- TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
- TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
- Revenues YoY using available TTM or quarter comparison; basis shown per metric
- Net Income YoY using available TTM or quarter comparison; basis shown per metric
CIK / security context first